| Typicality: | 0.406 |
| Saliency: | 0.366 |
| in the market | 10 | location |
| to his successful contested proxy | 5 | other |
| to clinical trials | 3 | other |
| expense → be incurred → related | 14 |
| expense → be incurred → relate | 14 |
| negative | neutral | positive |
| 0.072 | 0.818 | 0.110 |
| Raw frequency | 28 |
| Normalized frequency | 0.366 |
| Modifier score | 0.500 |
| Perplexity | 464.535 |